This observation is in line with mouse model studies on CD103+ cDC1s, such that the expansion and activation of CD103+ DCs dramatically increased CD8+ T cell recruitment to the tumor site and transformed response to checkpoint blockade (Roberts et al., 2016; Salmon et al., 2016). This evidence concerns the gene CD8A and neoplasm.